Sviluppo ed immissione nel mercato di farmaci salvavita per malattie rare

Records

Official question E-10-2025-002031 from European Union at European Parliament. Dated 21 May 2025. Status: answered.

Timeline

1. 21 May 2025

   Written question

   Sviluppo ed immissione nel mercato di farmaci salvavita per malattie rare

   Source: QUESTION_WRITTEN

2. 24 September 2025

   Answer

   Source: QUESTION_WRITTEN_ANSWER

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

5 official files

• Answer

  QUESTION_WRITTEN_ANSWER · 24 September 2025

  ViewDownloadOpen at official source

• Development of life-saving medicines for rare diseases and bringing them to market

  QUESTION_WRITTEN · EN · 11 June 2025

  DownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Development of life-saving medicines for rare diseases and bringing them to market

  QUESTION_WRITTEN · EN · 11 June 2025

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Sviluppo ed immissione nel mercato di farmaci salvavita per malattie rare

  QUESTION_WRITTEN · IT · 11 June 2025

  DownloadOpen at official source

  Reading translation

  Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

  Translate toEN · EnglishNL · DutchDE · GermanFR · FrenchES · SpanishPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Translate document

  On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

• Sviluppo ed immissione nel mercato di farmaci salvavita per malattie rare

  QUESTION_WRITTEN · IT · 11 June 2025

  ViewDownloadOpen at official source

  Reading translation

  Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.

  Translate toEN · EnglishNL · DutchDE · GermanFR · FrenchES · SpanishPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Translate document

  On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.

Sponsors

• Aldo PATRICIELLO · AUTHOR
• Isabella TOVAGLIERI · AUTHOR
• Silvia SARDONE · AUTHOR
• Paolo BORCHIA · AUTHOR
• · COM · ADDRESSEE
• Anna Maria CISINT · AUTHOR

Related records

No cross-record relationships stored yet.